Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Refrigerator-Stable Zostavax Formulation Study
NCT00130793Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Aug 2005
- Primary completion
- Nov 2005
- Modality
- Live Attenuated Vaccines
01
Overview
A Phase 3 trial of varicella virus vaccine live in herpes zoster (HZ), sponsored by Merck & Co.. Started Aug 2005; status: completed.
02
Drugs
varicella virus vaccine live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT00130793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00130793.